Evidence map›Paper›PMID 21091634›Full record

ReviewJournal of cellular and molecular medicine2011

MicroRNA-196: critical roles and clinical applications in development and cancer.

Changyi Chen, Yuqing Zhang, Lidong Zhang, Sarah M Weakley, Qizhi Yao

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 5 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 5 syntheses or guidelines pooled it, 211 citations in OpenAlex.

  1. Epigenetic mechanisms in Tendon Ageing.British medical bulletin · 2020
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and cancer risk: evidence based on 45,816 subjects.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Changyi ChenMolecular Surgeon Research Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA. jchen@bcm.tmc.edu
Yuqing Zhang
Lidong Zhang
Sarah M Weakley
Qizhi Yao
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · US

Funding

Molecular Surgeon Research Training on Vascular DiseaseT32HL083774 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CHEN, CHANGYI · 2008 to 2012
$970k
Enhancement of dendritic cell vaccine efficiency against pancreatic cancer by MSKR21CA140828 · NCI · BAYLOR COLLEGE OF MEDICINE · PI YAO, QIZHI C. · 2009 to 2010
$371k
NCI NIH HHS R21 CA140828NCI NIH HHS R21CA140828NHLBI NIH HHS T32 HL083774NHLBI NIH HHS T32HL083774
6 · The paper itself

Abstract

The discovery of microRNAs (miRNAs) represents one of the most significant advances in biological and medical sciences in the last decade. Hundreds of miRNAs have been identified in plants, viruses, animals and human beings, and these tiny, non-coding RNA transcripts have been found to play crucial roles in important biological processes involved in human health and disease. Recently, many studies have demonstrated that miR-196 plays critical roles in normal development and in the pathogenesis of human disease processes such as cancer. Several investigations have implemented cell culture and animal models to explore the potential molecular mechanisms of miR-196. This review provides updated information about the structure of the miR-196 gene and the roles of miR-196 in development, cancer and disease formation. Importantly, we discuss the possible molecular mechanisms whereby miR-196 regulates cellular functions including targeting molecules and gene regulation pathways; potential clinical applications are addressed, as well as future directions for investigation. miR-196a may prove to be a novel therapeutic target for several cancers.

Indexed as

Gene Expression Regulation, DevelopmentalGene Expression Regulation, NeoplasticAnimalsHumansMicroRNAsNeoplasmsMicroRNAsMIRN196 microRNA, human

Identifiers

PMID21091634
PMCPMC3276076
OpenAlexW1964762016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.